{"component": "definition", "props": {"groups": [{"snippet": "has the meaning set forth in Section 1.3(a).", "samples": [{"hash": "bCtBnHWh8eH", "uri": "/contracts/bCtBnHWh8eH#first-milestone", "label": "Purchase and Sale Agreement (Galera Therapeutics, Inc.)", "score": 30.7741279602, "published": true}, {"hash": "lsmYQLURqGp", "uri": "/contracts/lsmYQLURqGp#first-milestone", "label": "Purchase and Sale Agreement (Galera Therapeutics, Inc.)", "score": 30.3059539795, "published": true}, {"hash": "bM1XihSid9E", "uri": "/contracts/bM1XihSid9E#first-milestone", "label": "Purchase and Sale Agreement", "score": 26.1704311371, "published": true}], "snippet_links": [], "size": 8, "hash": "328f873fa8a43b566d65067a8b6c2f5e", "id": 1}, {"snippet": "means that Blockstack has succeeded in making the Network operational with Token functionality and the Network is live and being actively used by participants.", "samples": [{"hash": "7BuZFP8xlkP", "uri": "/contracts/7BuZFP8xlkP#first-milestone", "label": "Limited Partnership Agreement (Blockstack Inc.)", "score": 30.5140323639, "published": true}, {"hash": "63Cbc1Egvg6", "uri": "/contracts/63Cbc1Egvg6#first-milestone", "label": "Limited Partnership Agreement (Blockstack Inc.)", "score": 30.5140323639, "published": true}, {"hash": "3A52NeGwPSx", "uri": "/contracts/3A52NeGwPSx#first-milestone", "label": "Limited Partnership Agreement (Blockstack Inc.)", "score": 30.5140323639, "published": true}], "snippet_links": [{"key": "the-network", "type": "definition", "offset": [46, 57]}, {"key": "token-functionality", "type": "clause", "offset": [75, 94]}, {"key": "by-participants", "type": "clause", "offset": [143, 158]}], "size": 6, "hash": "ef9d2c613887ac18e72b8fce65cf86b1", "id": 2}, {"snippet": "has the meaning set forth in Section 2.8.2 hereof.", "samples": [{"hash": "5wGpUFc9qH1", "uri": "/contracts/5wGpUFc9qH1#first-milestone", "label": "Amcs Development Agreement (Aurora Biosciences Corp)", "score": 18.0, "published": true}], "snippet_links": [], "size": 4, "hash": "94375652f2aa3a5c0fc96c5746df684f", "id": 3}, {"snippet": "means **.", "samples": [{"hash": "36wQEeI7P2f", "uri": "/contracts/36wQEeI7P2f#first-milestone", "label": "Stock Purchase Agreement (Biota Pharmaceuticals, Inc.)", "score": 26.3470230103, "published": true}, {"hash": "j2W2JdK5Ne", "uri": "https://investors.vaxart.com/static-files/66b01ef5-aa72-4399-925c-7b13a3f00c71", "label": "investors.vaxart.com", "score": 9.96235466, "published": false}, {"hash": "i00h3ZWx45L", "uri": "https://investors.aviragentherapeutics.com/static-files/66b01ef5-aa72-4399-925c-7b13a3f00c71", "label": "investors.aviragentherapeutics.com", "score": 9.5653657913, "published": false}], "snippet_links": [], "size": 3, "hash": "9716ed9e370d1b12563c408480758ae1", "id": 4}, {"snippet": ", \"Second Milestone\", Third Milestone\", \"Fourth Milestone\", \"Fifth Milestone\", and \"Sixth Milestone\", respectively.", "samples": [{"hash": "fC6zFmG5r7L", "uri": "/contracts/fC6zFmG5r7L#first-milestone", "label": "Option Agreement (B Twelve Inc)", "score": 18.0, "published": true}, {"hash": "93244Mi2d7F", "uri": "/contracts/93244Mi2d7F#first-milestone", "label": "Option Agreement (B Twelve Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "second-milestone", "type": "definition", "offset": [3, 19]}, {"key": "third-milestone", "type": "definition", "offset": [22, 37]}, {"key": "fourth-milestone", "type": "definition", "offset": [41, 57]}, {"key": "fifth-milestone", "type": "definition", "offset": [61, 76]}], "size": 3, "hash": "baaeb2161c0e6c93a6896210415cf22f", "id": 5}, {"snippet": "means [*******]", "samples": [{"hash": "lUmDkaYIjpk", "uri": "/contracts/lUmDkaYIjpk#first-milestone", "label": "License Agreement (Innerdyne Inc)", "score": 18.0, "published": true}], "snippet_links": [], "size": 3, "hash": "75d58ebefceb1770920fedad2a39cd88", "id": 6}, {"snippet": "means the *** Successful implantation of a \u201cPROW FUSION-V\u201d product within the Prow Fusion-V Product Family.", "samples": [{"hash": "jov3020tku5", "uri": "/contracts/jov3020tku5#first-milestone", "label": "Asset Purchase Agreement (SeaSpine Holdings Corp)", "score": 27.8583164215, "published": true}, {"hash": "bImnDj5ua9g", "uri": "https://investor.seaspine.com/static-files/b77dc768-f8d5-4dec-af74-dd6f23189118", "label": "investor.seaspine.com", "score": 9.9952087402, "published": false}], "snippet_links": [{"key": "product-family", "type": "definition", "offset": [92, 106]}], "size": 2, "hash": "2521c011e2ecc1da4048ddc25de9b0c2", "id": 7}, {"snippet": "means the achievement of the successful production and testing of Osmolarity Alpha/Alpha Units as further described on Schedule 1.4(c)(i) hereto; and \u201cSecond Milestone\u201d means the achievement of the successful production and testing of (A) Osmolarity Beta/Beta Units and (B) IgE Alpha lab cards as further described on Schedule 1.4(c)(ii) hereto.", "samples": [{"hash": "bPGPdxdvj1K", "uri": "/contracts/bPGPdxdvj1K#first-milestone", "label": "Series a Preferred Stock Purchase Agreement (OccuLogix, Inc.)", "score": 21.0, "published": true}, {"hash": "75Cp8jg4mFU", "uri": "/contracts/75Cp8jg4mFU#first-milestone", "label": "Series a Preferred Stock Purchase Agreement (OccuLogix, Inc.)", "score": 21.0, "published": true}], "snippet_links": [{"key": "the-successful", "type": "clause", "offset": [25, 39]}, {"key": "on-schedule", "type": "definition", "offset": [116, 127]}, {"key": "second-milestone", "type": "definition", "offset": [151, 167]}], "size": 2, "hash": "1b17a91893bbfb3d928fa69fcbc99f26", "id": 8}, {"snippet": "means the milestone set forth on Annex A under the heading \u201cFirst Milestone.\u201d", "samples": [{"hash": "gP2ob5pQ0qS", "uri": "/contracts/gP2ob5pQ0qS#first-milestone", "label": "Merger Agreement (Abeona Therapeutics Inc.)", "score": 26.6153316498, "published": true}, {"hash": "f1bicASleme", "uri": "/contracts/f1bicASleme#first-milestone", "label": "Merger Agreement (Abeona Therapeutics Inc.)", "score": 26.6153316498, "published": true}], "snippet_links": [{"key": "annex-a", "type": "definition", "offset": [33, 40]}], "size": 2, "hash": "c91f6d684fcaed3a07a3dbe0a8969fa6", "id": 9}, {"snippet": "means the first milestone event to occur under Section 4.3.", "samples": [{"hash": "frnbd2UqWGe", "uri": "/contracts/frnbd2UqWGe#first-milestone", "label": "Exclusive License Agreement (Denali Therapeutics Inc.)", "score": 28.8658447266, "published": true}, {"hash": "2QsZW7AG7F4", "uri": "/contracts/2QsZW7AG7F4#first-milestone", "label": "Exclusive License Agreement (Denali Therapeutics Inc.)", "score": 28.8193016052, "published": true}], "snippet_links": [{"key": "first-milestone-event", "type": "definition", "offset": [10, 31]}, {"key": "section-43", "type": "clause", "offset": [47, 58]}], "size": 2, "hash": "8d7871801bd2914b2a0ad24a404558fd", "id": 10}], "next_curs": "ClwSVmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjgLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIYZmlyc3QtbWlsZXN0b25lIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "has the meaning set forth in Section 1.3(a).", "title": "First Milestone", "size": 108, "id": "first-milestone", "examples": ["Until the date of the Additional Issuance upon the achievement of the <strong>First Milestone</strong>, \u2587\u2587\u2587\u2587\u2587\u2019s Board of Directors shall not appoint additional Directors to exceed the Number of Directors."], "related": [["development-milestone", "Development Milestone", "Development Milestone"], ["milestone-1", "Milestone 1", "Milestone 1"], ["performance-milestone", "Performance Milestone", "Performance Milestone"], ["project-milestone", "Project Milestone", "Project Milestone"], ["milestone-date", "Milestone Date", "Milestone Date"]], "related_snippets": [], "updated": "2026-07-18T04:26:07+00:00"}, "json": true, "cursor": ""}}